STOCK TITAN

Co-Diagnostics borrows $1M via secured convertible note

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Co-Diagnostics, Inc. (CODX) borrowed an additional $1.0 million loan from J.J. Astor & Co. on November 18, 2026, issuing a senior secured convertible note with $1.35 million original principal. After a $40,000 origination fee, net proceeds were $960,000 before other expenses; the company intends to use them for general working capital.

The note requires 30 weekly installments of $45,000 beginning November 25, 2026, and matures June 16, 2027. It is secured by a senior-priority lien on substantially all company and existing subsidiary assets. The conversion price is the greater of 90% of the lowest common-stock volume-weighted average price during the prior 10 trading days or Nasdaq’s minimum price, subject to a floor of 20% of that minimum. If paid in full within 45 days and no default has occurred, repayment uses a 1.29 factor rate less installments already paid.

On default, principal on notes under the loan agreement rises to 120% of then-outstanding principal, with 19% annual interest compounded daily. The company must make its previously approved reverse split effective on or before November 24, 2026; failure is an event of default. Waived funding conditions included a $1.00 prior-day closing price, at least five business days’ notice and prior effectiveness of the split.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 2 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • None.

Negative

  • Major pointCODX’s $1.35 million note is secured by a senior-priority lien on substantially all company and existing subsidiary assets. 99% of market cap
  • Moderate point. Forward-looking: it has not happened yet and may not happen.The reverse split must be effective by November 24, 2026, or failure constitutes an event of default.

Filing Explained

Every six months, the note’s conversion floor may reset to the lower of its current floor or 20% of the stock’s lowest volume-weighted average price over the prior 20 trading days, but cannot fall below 20% of Nasdaq’s minimum price without stockholder approval, and a lower floor can mean more shares issued on conversion and greater dilution if converted.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Additional Loan funded $1.0 million Funded November 18, 2026
Additional Note original principal $1.35 million Senior secured convertible installment promissory note
Net proceeds $960,000 Before other transaction expenses
Installment amount $45,000 Each weekly installment
Installment count 30 weekly installments Beginning November 25, 2026
Conversion price benchmark 90% of the lowest volume-weighted average price Lowest price during the 10 consecutive trading days preceding conversion
Conversion price floor 20% of Nasdaq’s minimum price Subject to the note’s floor-price terms
Default interest 19% per annum, compounded daily Applies upon an event of default
factor rate financial
"reflects a factor rate of 1.35 times the funded amount"
senior-priority lien financial
"secured by a senior-priority lien on substantially all assets"
volume-weighted average price financial
"lowest volume-weighted average price of the common stock"
Volume-weighted average price (VWAP) is the average price of a stock over a specific time period where each trade is weighted by the number of shares traded, so larger trades influence the average more than small ones. Investors and traders use VWAP as a reference point to judge whether trades are happening at relatively good or poor prices—like checking the average price paid for an item at a market where bulk purchases count more than single-item buys.
floor price financial
"the floor price then in effect"
The floor price is the minimum price at which a security, asset, or offering will be sold or accepted, acting like a seller’s “bottom line” or a reserve in an auction. For investors it matters because it sets a visible downside limit and can influence trading, valuation, and expectations of risk—like knowing there’s a safety net that a sale won’t go below a set level.
event of default financial
"failure to do so constitutes an event of default"
An event of default is a specific breach of a loan or bond agreement—such as missed payments or breaking agreed rules—that gives lenders the legal right to act, for example by demanding immediate repayment, seizing collateral, or accelerating other obligations. For investors, it’s a red flag because it can sharply reduce a company’s ability to operate or raise money, like a car lender repossessing a vehicle after missed payments, and often leads to falling share or bond prices.
accredited investor regulatory
"represented that it is an “accredited investor”"
An accredited investor is an individual or entity that meets certain financial criteria, such as having a high income or significant net worth, allowing them to invest in private or less regulated investment opportunities. This status matters because it grants access to investments that are often riskier or less available to the general public, reflecting a higher level of financial knowledge or resources.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did CODX receive under the additional loan?

CODX received $960,000 in net proceeds after the lender retained a $40,000 origination fee, before other transaction expenses; the lender funded $1.0 million.

What are the repayment terms of CODX’s additional note?

The note requires 30 weekly installments of $45,000 beginning November 25, 2026, and has a final maturity date of June 16, 2027. CODX may prepay at any time without penalty.

How is the conversion price for CODX’s note determined?

The lender may convert all or any portion of the payment amount at the greater of 90% of the lowest volume-weighted average price during the preceding 10 trading days or Nasdaq’s minimum price, subject to a floor equal to 20% of Nasdaq’s minimum price.

When must CODX make its reverse split effective under the loan terms?

CODX must make its previously approved reverse split effective on or before November 24, 2026; failure to do so constitutes an event of default under the Additional Note.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001692415 0001692415 2026-11-18 2026-11-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 18, 2026

 

CO-DIAGNOSTICS, INC.

(Exact name of registrant as specified in its charter)

 

Utah 001-38148 46-2609363

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

 

2401 S. Foothill Drive, Suite D, Salt Lake City, Utah 84109

(Address of principal executive offices) (Zip Code)

 

(801) 438-1036

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value per share   CODX   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

Funding of Additional Loan

 

On November 18, 2026, Co-Diagnostics, Inc. (the “Company”) borrowed the additional loan contemplated by the Loan Agreement, dated as of October 9, 2026 (the “Loan Agreement”), between the Company and J.J. Astor & Co. (the “Lender”) as disclosed in the Company’s Current Report on Form 8-K filed on October 13, 2026. The Lender funded $1.0 million (the “Additional Loan”), and the Company issued to the Lender a senior secured convertible installment promissory note having an original principal amount of $1.35 million (the “Additional Note”). The original principal amount of the Additional Note reflects a factor rate of 1.35 times the funded amount. The Lender retained a $40,000 origination fee, resulting in net cash proceeds to the Company of $960,000 before other transaction expenses. The Company intends to use the net proceeds for general working capital purposes.

 

The Additional Note has an original issue date of November 18, 2026, requires 30 weekly installment payments of $45,000 beginning November 25, 2026, and has a final maturity date of June 16, 2027. The Additional Note is secured by a senior-priority lien on substantially all assets of the Company and its existing subsidiaries as subsidiary guarantors pursuant to that certain Pledge and Security Agreement, dated October 9, 2026 and the Subsidiary Guarantee dated October 9, 2026.

 

The Company may prepay the Additional Note at any time without penalty. If the Additional Note is paid in full within 45 days after its funding date and no event of default has occurred, the repayment amount will be reduced to reflect a factor rate of 1.29 times the applicable funded amount, less all weekly installment payments previously made. Upon an event of default, the outstanding balance becomes immediately due and payable, the outstanding principal amount of all notes issued under the Loan Agreement is increased to 120% of the then-outstanding principal amounts, bear default interest at 19% per annum, compounded daily (the “Default Amount”) and may be converted by the Lender at the event of default Conversion Price (as defined in the Loan Agreement).

 

The Lender may convert all or any portion of the payment amount under the Additional Note into shares of the Company’s common stock (the “Conversion Shares”) at a conversion price equal to the greater of (i) 90% of the lowest volume-weighted average price of the common stock during the 10 consecutive trading days immediately preceding the conversion date and (ii) the minimum price determined under applicable Nasdaq listing rules, subject to a floor price equal to 20% of the Nasdaq minimum price and other customary adjustments. On the six-month anniversary of the execution of the Loan Agreement, and every six months thereafter, the floor price will be reset to the lower of (i) the floor price then in effect or (ii) 20% of the lowest volume weighted average price of the Company’s common stock during the twenty trading days preceding such reset; provided that the floor price will not be reduced below 20% of the Nasdaq minimum price unless and until the Company obtains stockholder approval.

 

In connection with the funding, the Company and the Lender agreed to waive certain conditions under the Loan Agreement that otherwise would have required the Additional Loan to be requested and funded no earlier than December 8, 2026 and on at least five business days’ notice. The parties also waived the conditions that the closing price of the Company’s common stock on the trading day immediately preceding the funding date be at least $1.00 per share and that the Company’s previously approved reverse stock split has become effective before the funding date. The Company is required to cause the reverse stock split to become effective on or before November 24, 2026, and failure to do so constitutes an event of default under the Additional Note. The waiver does not waive any other condition to funding the Additional Loan.

 

The foregoing description of the Additional Note does not purport to be complete and is qualified in its entirety by reference to the full text of the Additional Note, which is filed as Exhibit 4.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

2
 

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02.

 

The Company issued the Additional Note in reliance on the exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), provided by Section 4(a)(2) thereof and/or Rule 506(b) of Regulation D promulgated thereunder. The Lender represented that it is an “accredited investor” as defined in Rule 501(a) of Regulation D. Neither the Additional Note nor any shares of common stock issuable upon conversion of the Additional Note have been registered under the Securities Act. Any such shares issued absent registration may not be offered or sold in the United States absent registration or an applicable exemption from registration.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
4.1   Senior Secured Convertible Note issued to J.J. Astor & Co., dated November 18, 2026.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

3
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CO-DIAGNOSTICS, INC.
Dated: November 20, 2026    
  By: /s/ Dwight H. Egan
  Name: Dwight H. Egan
  Title: Chief Executive Officer

 

4

 

Filing Exhibits & Attachments

4 documents

Keep reading